Influence of uridine diphosphate-glucuronosyltransferases (1A9) polymorphisms on mycophenolic acid pharmacokinetics in patients with renal transplant.
Ciftci, H S
Influence of uridine diphosphate-glucuronosyltransferases (1A9) polymorphisms on mycophenolic acid pharmacokinetics in patients with renal transplant. [electronic resource] - Renal failure Nov 2018 - 395-402 p. digital
Publication Type: Journal Article
1525-6049
10.1080/0886022X.2018.1489285 doi
Adult
Female
Follow-Up Studies
Genotype
Glucuronosyltransferase--genetics
Graft Rejection--epidemiology
Humans
Immunosuppressive Agents--pharmacokinetics
Kidney Failure, Chronic--surgery
Kidney Transplantation--adverse effects
Male
Middle Aged
Mycophenolic Acid--pharmacokinetics
Polymerase Chain Reaction
Polymorphism, Single Nucleotide
Treatment Outcome
Turkey
UDP-Glucuronosyltransferase 1A9
Influence of uridine diphosphate-glucuronosyltransferases (1A9) polymorphisms on mycophenolic acid pharmacokinetics in patients with renal transplant. [electronic resource] - Renal failure Nov 2018 - 395-402 p. digital
Publication Type: Journal Article
1525-6049
10.1080/0886022X.2018.1489285 doi
Adult
Female
Follow-Up Studies
Genotype
Glucuronosyltransferase--genetics
Graft Rejection--epidemiology
Humans
Immunosuppressive Agents--pharmacokinetics
Kidney Failure, Chronic--surgery
Kidney Transplantation--adverse effects
Male
Middle Aged
Mycophenolic Acid--pharmacokinetics
Polymerase Chain Reaction
Polymorphism, Single Nucleotide
Treatment Outcome
Turkey
UDP-Glucuronosyltransferase 1A9